He argues that current AI safety legislation (e.g., chatbot laws) is less critical than improving drug approval processes, which will face bottlenecks from AI-driven discoveries.
I don't worry as much about the chatbot laws. I actually worry more about the drug approval process, where I think AI models are going to greatly accelerate the rate at which we discover drugs, and the pipeline will get jammed up.